Ablation of atrial fibrillation in patients with Brugada syndrome: A systematic review of the literature

Journal of Arrhythmia
Moisés Rodríguez-MañeroJosé Ramón González-Juanatey

Abstract

Supraventricular arrhythmias are common in Brugada syndrome (BS), and notoriously difficult to manage with medical therapy secondary to associated risks. Pulmonary vein isolation (PVI) is often utilized instead, but its outcomes in this population are not well-known. We aim to provide a holistic evaluation of interventional treatment for Atrial fibrillation (AF) in the BS population. Electronic databases Medline, Embase, Cinahl, Cochrane, and Scopus were systematically searched for publications between 01/01/1995 and 12/31/2017. Studies were screened based on predefined inclusion and exclusion criteria. A total of 49 patients with BS and AF were included. Age range from 28.8 to 64 years, and 77.5% were male. 38 patients were implanted with implantable cardioverter-defibrillators (ICD) at baseline, and of them, 39% suffered inappropriate shocks for rapid AF. 34/49 (69%) of patients achieved remission following a single PVI procedure. Of the remaining, 13 patients underwent one or more repeat ablation procedures. Overall, 45/49 (91.8%) of patients remained in remission during long-term follow-up after one or more PVI procedures in the absence of antiarrhythmic drug (AAD) therapy. Postablation, no patients suffered inappropriate I...Continue Reading

References

Oct 24, 2002·Journal of the American College of Cardiology·Hiroshi MoritaTohru Ohe
May 14, 2004·European Heart Journal·Pierre BordacharJacques Clementy
Jun 28, 2005·Scottish Medical Journal·G Lowe, Sara Twaddle
Jan 26, 2008·Circulation Journal : Official Journal of the Japanese Circulation Society·Takumi YamadaG Neal Kay
Sep 18, 2009·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Christian VeltmannChristian Wolpert
Aug 28, 2012·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·A John CammUNKNOWN Document Reviewers
Mar 30, 2013·Journal of the American Heart Association·Anand N GanesanPrashanthan Sanders
Apr 16, 2013·Journal of the American College of Cardiology·Sami ViskinRaphael Rosso
Oct 11, 2013·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Giulio ContePedro Brugada
Feb 12, 2014·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Carla GiustettoAnna Ferraro
Mar 25, 2017·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Giacomo MugnaiGian-Battista Chierchia

❮ Previous
Next ❯

Citations

Jul 30, 2019·Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·Jakrin KewcharoenWasawat Vutthikraivit
Jan 22, 2020·Journal of Cardiovascular Electrophysiology·Konstantinos VlachosFrédéric Sacher

❮ Previous
Next ❯

Software Mentioned

Cochrane
Embase
Cinahl
Scopus

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Related Papers

Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology
Giulio ContePedro Brugada
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology
Giacomo MugnaiGian-Battista Chierchia
Circulation. Arrhythmia and Electrophysiology
Wendy S TzouEdward P Gerstenfeld
© 2022 Meta ULC. All rights reserved